Meeting
2019 Gastrointestinal Cancers Symposium
Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation: Interim results.
Authors
Mikaela Esquivel
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Mikaela Esquivel , Bryant Chee , Brandon Shih , Li Zhang , Carlos U. Corvera , Kenzo Hirose , Eric K. Nakakura , Katherine Van Loon , Victoria M. Raymond , Daniel Dix , Justin Odegaard , Chloe Evelyn Atreya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 552)
DOI
10.1200/JCO.2019.37.4_suppl.552
Abstract #
552
Poster Bd #
F15
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation.
First Author: Bryant Chee
Poster
2023 ASCO Annual Meeting
Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with surgically resected stage II/III melanoma.
First Author: Revathi Kollipara
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prediction of postoperative recurrence by integrating preoperative ctDNA levels and tumor metastasis volume in patients (pts) with colorectal cancer (CRC) with resectable lung or liver metastasis.
First Author: Hidekazu Oyoshi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Surveillance of resected metastatic colorectal cancer utilizing circulating DNA.
First Author: Nikolas Naleid